1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Outcomesa
Overall (n = 28) Type A (n = 5) B (n = 6) C (n = 4) D (n = 13) Normal patency of ophthalmic arteryb Immediately after procedure 24 (85.7) 5 (100) 5 (83.3) 2 (50.0) 12 (92.3) At 3 mo 27 (96.4) 5 (100) 6 (100) 4 (100) 12 (92.3) At 12 mo 27 (96.4) 5 (100) 6 (100) 4 (100) 12 (92.3) Ophthalmic complications Retinal emboli 5 (17.9) 4 (80.0) 0 0 1 (7.7) Optic atrophy 3 (10.7) 0 0 3 (75.0) 0 New clinical symptoms 11 (39.3) 4 (80.0) 1 (16.7) 3 (75.0) 3 (23.1) Transient 6 (21.4) 1 (20.0) 1 (16.7) 1 (25.0) 3 (23.1) Permanent 5 (17.9) 3 (60.0) 0 2 (50.0) 0